HUMA
HUMA
Company information not available. Track real-time insider trading activity, SEC Form 4 filings, and executive stock transactions.
Insider Buys
14
$272K
Insider Sales
6
$20.76M
Total Volume
$21.03M
33 transactions
Net Activity
$20.49M
Net selling
Sentiment Rating
Moderate AccumulationCEO Conviction Index
High Conviction Accumulation
Key Drivers
- •Heavy distribution: sales represent 99% of total transaction value.
- •Cluster buying: 9 unique insiders purchased shares, showing strong alignment.
- •CEO buying activity detected. When chief executives put their own money at risk, it is historically a strong bullish signal.
- •CFO buying activity detected. Statistical studies show CFO purchases have high predictive power due to their direct visibility into balance sheet details.
- •Significant liquidation: total sale value exceeds $10M.
Score Methodology
The Insider Confidence Score (1-100) measures executive conviction. Starting from a neutral 50, it adjusts based on:
- +15Strong Buy Ratio: Purchases > 70% of volume (or up to -15 for heavy sales).
- +20Cluster Buying: ≥3 unique insiders buying within a 30-day window.
- +15CEO Buying: CEO committing own capital shows high conviction.
- +10CFO Buying: CFO purchasing shares shows financial alignment.
Multiple Insiders
P - Purchase Insiders
$23.38B total
Dougan Brady W
Dir
$10.35M total
Niklason Laura E
Pres, CEO, Dir
$10.35M total
Sebelius Kathleen
Dir
$116K total
Sander Dale A.
CFO, Chief Corp. Dev. Off
$72K total
Quick Actions
HUMA has an insider buy conviction of 1%, compared to the Unknown sector buy average of 6%.
Over the last 90 days, corporate insiders at HUMA (HUMA) engaged in a total of 33 transactions reported via SEC Form 4 filings. Among these, 14 were open-market purchases and 6 were sales. The total volume of insider trading reached $21.03M.
The net insider activity for HUMA shows a net selling bias of $20.49M. This activity represents a 1% buy ratio, suggesting that insiders are currently bearish on the company's near-term outlook relative to recent history.
The most notable individual transaction was a Sale by Multiple Insiders (P - Purchase Insiders), who traded 148.0K shares valued at $8.41B on May 19, 2026.
Humacyte(HUMA) Stock Options Chain | Quotes & News
Humacyte, Inc. (HUMA) Stock Drops Despite Market Gains: Important Facts to Note
Humacyte Submits Supplemental Biologics License Application to FDA for the Acellular Tissue Engineered Vessel in Dialysis Access
Humacyte, Inc. (HUMA) Stock Slides as Market Rises: Facts to Know Before You Trade
Humacyte Stock (HUMA) Opinions on Phase 3 Trial Results
Humacyte, Inc. (HUMA) Sees a More Significant Dip Than Broader Market: Some Facts to Know
FAQs About HUMA Insider Trading
Answers to common questions regarding corporate filings and executive sentiment for HUMA.